Borrelia burgdorferi basic membrane protein A initiates proinflammatory chemokine storm in THP 1-derived macrophages via the receptors TLR1 and TLR2

Publication date: July 2019Source: Biomedicine &Pharmacotherapy, Volume 115Author(s): Hua Zhao, Xiting Dai, Xinlin Han, Aihua Liu, Fukai Bao, Ruolan Bai, Zhenhua Ji, Miaomiao Jian, Zhe Ding, Manzama-Esso Abi, Taigui Chen, Lisha Luo, Mingbiao Ma, Lvyan TaoAbstractLyme disease, reffered to as Lyme borreliosis, is a tick-borne zoonotic disease caused by Borrelia burgdorferi spirochetes. Lyme arthritis, the most common, serious and harmful manifestation during the late stages of Lyme disease, is closely associated with the Borrelia burgdorferi basic membrane protein A (BmpA). Chemokines are also reported to have an important role in Lyme arthritis. Toll-like receptors (TLRs) recognize and bind to pathogen-associated molecules which are structurally conserved among microbes, to activate transcriptional events, including cytokine production, inflammation, and tissue damage. We speculated that BmpA could induce a storm of proinflammatory chemokines via TLRs and downstream moleculars, and that TLR1, TLR2, TLR5, TLR6 and the adaptor protein, MyD88, may be involved in this process. We explored this hypothesis using the human monocytic leukemia cell line, THP-1, and recombinant BmpA (rBmpA). Cell surface TLR1 and TLR2 were neutralized using specific antibodies before stimulation with rBmpA and analysis of chemokine secretion using a chemokine chip. Further, the expressions level of the four TLRs and MyD88 were analyzed following stimulation with rBmpA. Stimulation with rBmpA resulte...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research

Related Links:

ConclusionThe findings declare that inhibition ofPVT1 could be a new target in the treatment of AML-M0 and help to approach more to treatments with fewer side effects.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
Conditions:   Leukemia;   Lymphoma;   Lymphoma, B-Cell Intervention:   Biological: CAR T-Cell Infusion Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   B-cell Acute Lymphoblastic Leukemia;   Refractory B Acute Lymphoblastic Leukemia;   Relapsed B-cell Acute Lymphoblastic Leukemia Intervention:   Drug: Blinatumomab Sponsors:   Michael Burke;   Amgen Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   B Acute Lymphoblastic Leukemia Intervention:   Drug: PBLTT52CAR19 Sponsors:   Great Ormond Street Hospital for Children NHS Foundation Trust;   University College, London Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Rheumatoid Arthritis;   Quality of Life Interventions:   Other: COVID-19 survey;   Other: RAPID-3;   Other: WHOQOL-BREF;   Other: DASS-21 instrument (depression and anxiety);   Other: IER-R (posttraumatic stress) Sponsor:   National Institute of Medical Sciences and Nutrition, Salvador Zubiran Recruiting
Source: - Category: Research Source Type: clinical trials
Physical inactivity significantly affects disease burden and reduces the overall quality of life in patients with knee osteoarthritis (OA), according to a study from Losina et al. The researchers calculated the total quality-adjusted life-years lost for U.S. patients with OA due to inactivity.
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions Osteoarthritis Arthritis Care & Research knee Knee Osteoarthritis (OA) Source Type: research
(University of Oxford) The strongest evidence yet of a single cause for psoriatic arthritis has been discovered by researchers. The disease may be activated by the same trigger in different patients which, if identified, could move towards creating therapies that would prevent psoriatic arthritis, and potentially providing a cure.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(University of Pennsylvania School of Medicine) New research has uncovered the previously unknown presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB). This discovery may potentially be the cause for neurotoxicity in patients undergoing CD19 directed CAR T cell immunotherapy, according to the research team led by Avery Posey, PhD, an assistant professor of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia. Oncol Rep. 2020 Aug 10;: Authors: Xu Y, Lin Y, Luo Y, Yang Y, Long B, Fang Z, Liu L, Zhang J, Zhang X Abstract RAD52 (Radiation sensitive 52) is a key factor in DNA damage repair (DDR) bypass, which participates in single‑strand annealing (SSA) after DNA damage end excision, while breast cancer type 1 susceptibility protein (BRCA1)/breast cancer type 2 susceptibility protein (BRCA2) play critical roles in homologous recombination (HR) repair. The present study aimed to determine whether RAD52...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
Gambogic acid inhibits proliferation and induces apoptosis of human acute T‑cell leukemia cells by inducing autophagy and downregulating β‑catenin signaling pathway: Mechanisms underlying the effect of Gambogic acid on T‑ALL cells. Oncol Rep. 2020 Aug 11;: Authors: Wang T, Du J, Kong D, Yang G, Zhou Q, You F, Lin Y, Wang Y Abstract The main active compound of Garcinia hanburyi (referred to as gamboge) is gambogic acid (GA), which has long been a Chinese herbal medicine for treating several types of cancer. However, the potential therapeutic role and mechanisms of GA in T‑cell acute lymphob...
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
More News: Arthritis | Borrelia | Drugs & Pharmacology | Leukemia | Lyme Disease | Rheumatology | Tickborne Diseases | Zoonoses